This page is part of the 臺灣核心實作指引(TW Core IG) (v0.2.1: Releases) based on FHIR (HL7® FHIR® Standard) R4 . This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
CodeSystem: 臺灣食藥署藥品藥理治療分類ATC碼
Official URL : https://twcore.mohw.gov.tw/ig/twcore/CodeSystem/medcation-atc-tw
Version :
2022-10-24
Active
as of 2014-09-19
Computable Name : TWMedcationATC
Copyright/Legal : 衛生福利部食品藥物管理署
臺灣食藥署藥品藥理治療分類ATC碼,參照至https://data.gov.tw/dataset/9119 ,資料提供單位:衛生福利部食品藥物管理署。
此代碼為WHO ATC(http://www.whocc.no/atc)中未涵蓋之代碼,為符合國內代碼使用,故將未被定義之代碼另外呈現。
因原始資料無代碼版本資訊,故使用其「更新日期」作為版本資訊。
This Code system is referenced in the content logical definition of the following value sets:
This CodeSystem is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Properties
This code system defines the following properties for its concepts
Code Type Description
updateDate
string
異動日期
event
string
異動方式
Concepts
This case-sensitive code system https://twcore.mohw.gov.tw/ig/twcore/CodeSystem/medcation-atc-tw
defines the following codes:
Code Display updateDate event
A10BD27
metformin, linagliptin and empagliflozin
2014-09
新增
A16AB22
avalglucosidase alfa
2014-09
新增
C03DA05
finerenone
2014-09
新增
D11AH08
abrocitinib
2014-09
新增
G04BD14
imidafenacin
2014-09
新增
H01AC08
somatrogon
2014-09
新增
H01BA06
argipressin
2014-09
新增
J05AB04
ribavirin
2014-09
新增
J05AX11
elvitegravir
2014-09
新增
J05AX12
dolutegravir
2014-09
新增
J05AX67
ombitasvir, paritaprevir and ritonavir
2014-09
新增
J05AX68
elbasvir and grazoprevir
2014-09
新增
L01EX22
selpercatinib
2014-09
新增
L01FX18
amivantamab
2014-09
新增
L01XE01
imatinib
2014-09
新增
L01XE03
erlotinib
2014-09
新增
L01XE06
dasatinib
2014-09
新增
L01XE10
everolimus
2014-09
新增
L01XE11
pazopanib
2014-09
新增
L01XE31
nintedanib
2014-09
新增
L01XX14
tretinoin
2014-09
新增
L01XX17
topotecan
2014-09
新增
L01XX19
irinotecan
2014-09
新增
L01XX32
bortezomib
2014-09
新增
L01XX73
sotorasib
2014-09
新增
L04AA52
ofatumumab
2014-09
新增
N05CM21
lemborexant
2014-09
新增